|
OXYCONTIN LAWYERS
If you or your family has suffered because of OxyContin, the
manufacturer may have been negligent and failed in its duty to design, make,
inspect and label the product appropriately. Please
contact the oxycontin lawyers of Brown & Crouppen today for your free
initial consultation. Our experienced team of lawyers, medical professionals and
investigators would like to represent you and help equal the odds of your
winning a fair settlement or award from the companies who have put dangerous
drugs into the hands of consumers.
FREE CASE EVALUATION >
|
 |
|
Oxycontin:
Prescription Drug Abuse- CSAT Advisory, Breaking News for the
Treatment Field 
This premiere issue of the CSAT Advisory focuses on the growing
use and abuse of OxyContin®, as well as on its addiction potential.
The CSAT Advisory provides FAQs about OxyContin, general information
about semisynthetic opioids and their addiction potential, summarizes
evidence-based protocols for treatment, and provides you with referral
sources for further information. -
U.S. Department of Health & Human
Services
National Drug
Intelligence Center
Information Bulletin OxyContin Diversion and Abuse
This bulletin addresses the diversion and abuse of the prescription
pain reliever OxyContin and the impact of abuse, particularly in the
eastern United States. This Publication provides substantive
information about the background of Oxycontin, spread of abuse,
related legislation, criminal activity, and outlook.
The Pitfalls of Opioids
for Chronic Nonmalignant Pain of Central Origin
- from Medscape Rheumatology
The treatment of pain of
central origin should focus on attenuating the causative and
perpetuating psychobiological factors, rather than masking them with
exogenous opioids. The risk of long-term dependency or addiction by
their direct effects on the emotional component of pain while
depleting the brain's natural endogenous opioids should make opioids a
last resort for treatment of chronic, nonmalignant pain....
continue >
DEA Reports Higher Rates of OxyContin-Related Deaths
Manufacturer disputes agency's findings
The prescription painkiller OxyContin may
have played a role in 464 overdose-related deaths over the past two
years, a rate much higher than previously reported, according to the
Drug Enforcement Administration (DEA) in an ongoing study of autopsy
reports related to oxycodone or the product, OxyContin....
continue >
DEA Fact Sheet: Drugs and Chemicals of
Concern Oxycodone
Oxycodone abuse has been a
continuing problem in the United States since the early 1960's.
Drug abuse treatment centers, law
enforcement personnel, and health care professionals have reported a
dramatic increase in the abuse...
continue >
Purdue Pharma's "Dear Health Care
Professional" letter warning physicians of the associated dangers of
Oxycontin
|
|
|
|
